Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Journal of Community Psychology|May 31, 2022
Microaggressions: Mega problems or micro issues? A meta-analysisPaula L Costa, Jessica W McDuffie, Stephanie E V Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2005
The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactionsFred Schaufele, Xavier Carbonell, Martin Guerbadot, et al.
Rheumatology (Oxford, England)|January 18, 2018
Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysisMary C Wallace, Rebecca L Roberts, Payal Nanavati, et al.
Molecular Endocrinology (Baltimore, Md.)|January 4, 2003
A nonsteroidal glucocorticoid receptor antagonistJeffrey N Miner, Curtis Tyree, Junlian Hu, et al.
The American Journal of Pathology|December 29, 2023
Role of Hepatic Stellate and Liver Sinusoidal Endothelial Cells in a Human Primary Cell Three-Dimensional Model of Nonalcoholic SteatohepatitisPhilip K Tan, Traci Ostertag, Sara B Rosenthal, et al.
RMD Open|April 17, 2018
Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label studyRoy Fleischmann, Peter Winkle, Jesse Hall, et al.
Endocrinology|December 8, 2007
Cell-specific activation of the human skeletal alpha-actin by androgensMei Hua Hong, Hong Sun, Cheng He Jin, et al.
RMD Open|March 14, 2018
Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label studyRoy Fleischmann, Peter Winkle, Jeffrey N Miner, et al.
Rheumatology (Oxford, England)|February 11, 2014
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemiaRoy Fleischmann, Bradley Kerr, Li-Tain Yeh, et al.
Bioorganic & Medicinal Chemistry Letters|June 3, 2008
Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolinesSteven L Roach, Robert I Higuchi, Mark E Adams, et al.
Pageof 9